Mankind Pharma Ltd (MANKIND) — Financial Flexibility Index
Mankind Pharma Ltd (MANKIND) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of Rs19.08 Billion (operating CF Rs16.37 Billion minus capex Rs2.71 Billion) represents 0% of total liabilities (Rs132.85 Billion). Check MANKIND cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mankind Pharma Ltd Financial Flexibility Index (2019–2026)
Historical Financial Flexibility Index trend for Mankind Pharma Ltd across 8 annual periods. For the full cash flow conversion analysis, see Mankind Pharma Ltd (MANKIND) cash conversion ratio.
Annual Financial Flexibility Index for Mankind Pharma Ltd (2019–2026)
Year-by-year free cash flow to debt coverage for Mankind Pharma Ltd. Explore cash flow to debt ratio of Mankind Pharma Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.27x | Rs31.42 Billion | Rs25.16 Billion | Rs115.18 Billion | ▲ +25.2% |
| 2025 | 0.22x | Rs28.74 Billion | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.5% |
| 2024 | 1.06x | Rs25.35 Billion | Rs21.52 Billion | Rs23.87 Billion | ▼ -17.1% |
| 2023 | 1.28x | Rs26.45 Billion | Rs18.13 Billion | Rs20.67 Billion | ▲ +11.0% |
| 2022 | 1.15x | Rs32.65 Billion | Rs9.20 Billion | Rs28.31 Billion | ▲ +20.1% |
| 2021 | 0.96x | Rs14.50 Billion | Rs11.37 Billion | Rs15.10 Billion | ▲ +3.7% |
| 2020 | 0.93x | Rs12.98 Billion | Rs10.70 Billion | Rs14.02 Billion | ▲ +16.6% |
| 2019 | 0.79x | Rs8.98 Billion | Rs6.00 Billion | Rs11.31 Billion | — |